These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16159439)

  • 1. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
    Shi HR; Song WJ; Chen ZM; Wu QH
    Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX; Wu Y; Han HQ; Wang QH
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
    Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
    Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
    Zhang MZ; Qiao YH; Suo ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):848-52. PubMed ID: 19173831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
    Chen BY; Ye DF; Xie X; Chen HZ; Lü WG
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
    Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
    Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
    Hu YQ; Liu YJ
    Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of EVEC in ovarian carcinoma and its biological significance].
    Wang Q; Li XG; Zhang Y; Cao LQ; Deng ZH; Chen Y
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):676-80. PubMed ID: 21122382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance].
    Cheng YX; Feng J; Zhang XY; Fu TY; Yao Y
    Ai Zheng; 2004 Sep; 23(9):1026-30. PubMed ID: 15363195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients.
    Kassim SK; El-Salahy EM; Fayed ST; Helal SA; Helal T; Azzam Eel-D; Khalifa A
    Clin Biochem; 2004 May; 37(5):363-9. PubMed ID: 15087251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression and significance of VEGF mRNA and bFGF mRNA in the malignant neoplasms of ovary].
    Li L; Liu YZ; Wu YL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):406-8. PubMed ID: 12206019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
    Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
    Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
    Zhao Y; Zong ZH; Xu HM
    Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.
    Sowter HM; Corps AN; Evans AL; Clark DE; Charnock-Jones DS; Smith SK
    Lab Invest; 1997 Dec; 77(6):607-14. PubMed ID: 9426398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].
    Liu JR; Luo SK; Li J; Su C
    Ai Zheng; 2007 Jun; 26(6):652-6. PubMed ID: 17562275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
    Yang YQ; Li JC
    Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].
    Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
    Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.